Understanding IV Ketamine Infusion Dosing and Treatment Schedules: A Patient Guide From Healing and Psychiatry in Flagstaff, AZ
For individuals living with treatment-resistant depression (TRD), chronic mood disorders, or other mental health conditions that have not responded to conventional medications, IV Ketamine infusion therapy represents a meaningful advancement in psychiatric care. At Healing and Psychiatry in Flagstaff, AZ, patients frequently ask about how IV Ketamine infusion dosing works, what a realistic treatment schedule looks like, and how Spravato dosing equivalence to IV Ketamine factors into choosing the right therapeutic approach. This guide is designed to provide clear, evidence-based information to help you understand the clinical details behind IV Ketamine therapy so that you can have more productive conversations with your provider.
As interest in ketamine-based treatments continues to grow across Arizona and the broader United States in 2026, it is important for patients to understand the distinctions between different administration routes, how doses are determined, and what the overall treatment journey typically involves. Whether you are exploring IV Ketamine for the first time or evaluating it alongside other options like Spravato (esketamine), this guide covers the essentials.
What Is IV Ketamine and How Does It Work?
Ketamine was originally developed and approved by the FDA as an anesthetic agent, but over the past two decades, research has revealed its potential to help alleviate symptoms of treatment-resistant depression, anxiety, PTSD, and certain chronic pain conditions. When administered intravenously at sub-anesthetic doses, ketamine interacts with NMDA (N-methyl-D-aspartate) receptors in the brain, which may promote the formation of new neural connections-a process known as neuroplasticity.
Unlike traditional antidepressants, which can take weeks or even months to produce noticeable changes, many patients who receive IV Ketamine report experiencing symptom improvement within hours to days of their initial infusion. It is important to note, however, that individual responses vary significantly, and IV Ketamine is not a guaranteed solution for every patient. At Healing and Psychiatry, treatment plans are carefully individualized based on clinical assessment, medical history, and ongoing symptom monitoring.
Who May Benefit From IV Ketamine?
IV Ketamine therapy may be considered for adults who meet certain clinical criteria, including:
- A diagnosis of treatment-resistant depression, typically defined as inadequate response to two or more standard antidepressant medications
- Major depressive disorder (MDD) accompanied by suicidal ideation, under appropriate clinical supervision
- Certain anxiety disorders, PTSD, or OCD that have proven difficult to manage with first-line therapies
- Chronic pain conditions for which conventional treatments have provided insufficient relief
Healing and Psychiatry, serving patients throughout Flagstaff and surrounding areas of Northern Arizona, provides thorough evaluations to determine whether IV Ketamine is an appropriate option for each individual’s unique circumstances.
IV Ketamine Dosing: What Patients Should Know
One of the most common questions patients ask is about the specific dosing used during an IV Ketamine infusion. While protocols can vary between providers and clinical scenarios, the most widely studied and commonly used dose for mood disorders is 0.5 mg per kilogram of body weight, administered intravenously over a period of approximately 40 minutes.
How Dosing Is Determined
Dosing for IV Ketamine is weight-based, meaning that a patient’s body weight directly influences the amount of medication used during each infusion. In some cases, a provider may adjust the dose slightly-either higher or lower-depending on the patient’s clinical response, tolerance, and side-effect profile. Adjustments are made incrementally and always under close medical supervision.
Key factors that influence dosing decisions include:
- Body weight: The primary variable in calculating the initial dose
- Treatment response: How the patient responds to initial infusions may prompt dose refinements
- Side-effect tolerance: Dissociative effects, nausea, or blood pressure changes may necessitate adjustments
- Concurrent medications: Some medications may interact with ketamine, influencing dosing strategy
- Condition being treated: Chronic pain protocols, for example, may differ from depression-focused protocols
At Healing and Psychiatry in Flagstaff, AZ, all dosing decisions are made collaboratively between the patient and the treatment team, with safety and therapeutic effectiveness as the guiding priorities.
Understanding Spravato Dosing Equivalence to IV Ketamine
A question that comes up frequently in clinical conversations is how Spravato dosing equivalence to IV Ketamine should be understood. Spravato (esketamine) is an FDA-approved nasal spray formulation that contains the S-enantiomer of ketamine. While both treatments target similar receptor pathways in the brain, they differ substantially in their pharmacokinetics, bioavailability, administration routes, and dosing structures.
Key Pharmacological Differences
Spravato is administered intranasally at fixed doses of either 56 mg or 84 mg, whereas IV Ketamine uses the racemic form of the drug (containing both the S- and R-enantiomers) at weight-based doses typically starting at 0.5 mg/kg. The bioavailability of intranasal esketamine is estimated at roughly 48%, compared to the 100% bioavailability achieved through intravenous administration. This means that a significant portion of each Spravato dose is not absorbed into the bloodstream, creating a notable challenge when attempting to draw direct dosing comparisons.
Because of these pharmacological differences, establishing a straightforward Spravato dosing equivalence to IV Ketamine is not as simple as converting milligrams between the two formulations. The effective brain concentration, the speed of onset, the duration of the infusion or spray session, and the half-life of the active compounds all differ. As a result, clinicians generally approach each modality as a distinct treatment protocol rather than interchangeable options with a direct dose-conversion ratio.
Why the Distinction Matters for Patients
Understanding that Spravato dosing equivalence to IV Ketamine is not a one-to-one comparison is important for several reasons. First, it helps set realistic expectations when transitioning between treatments or comparing potential benefits. Second, it underscores the importance of working with an experienced provider who can evaluate which modality may be most appropriate based on your specific clinical profile. Third, it highlights that the two treatments, while related, have different evidence bases, regulatory statuses, and treatment protocols.
Healing and Psychiatry offers both IV Ketamine and Spravato treatments, allowing providers to recommend the option that best aligns with each patient’s needs, medical history, and treatment goals.
IV Ketamine Treatment Schedules: The Typical Patient Journey
Understanding the treatment schedule is just as important as understanding dosing. IV Ketamine therapy is typically delivered in two distinct phases: an initial induction phase and a longer-term maintenance phase.
The Induction Phase
During the induction phase, patients generally receive a series of six infusions over a period of two to three weeks. This concentrated schedule is designed to build a therapeutic effect and allows the treatment team to monitor response closely. Sessions are usually spaced two to three days apart, giving the patient time to rest between appointments while maintaining treatment momentum.
Each individual infusion session typically lasts approximately 40 minutes for the active infusion, with an additional observation period of 30 to 60 minutes afterward. During the observation window, clinical staff monitor vital signs, assess for side effects, and ensure the patient feels stable before discharge. Patients should plan for each appointment to take roughly one and a half to two hours in total.
The Maintenance Phase
After completing the induction series, patients who experience a positive response typically transition to a maintenance schedule. The frequency of maintenance infusions varies widely depending on the individual, but common schedules range from once every two weeks to once per month. Some patients may find they need less frequent sessions over time, while others may require adjustments during periods of increased stress or symptom recurrence.
The total number of sessions over a six-month period may range from approximately 11 to 18 infusions, depending on the maintenance frequency determined by the provider. This is notably fewer total clinic visits than many Spravato protocols require, which may involve up to 21 sessions over the same period. This difference in visit burden is one of many factors patients consider when evaluating their treatment options alongside questions about Spravato dosing equivalence to IV Ketamine.
What to Expect During an Infusion Session
Patients visiting Healing and Psychiatry for an IV Ketamine infusion can expect a calm, comfortable clinical environment. Here is a general overview of what a typical session involves:
- Pre-infusion check-in: Vital signs are taken, and the clinical team reviews any changes in symptoms, medications, or overall health since the last visit.
- IV placement: A small intravenous catheter is placed, typically in the arm or hand.
- Infusion administration: The ketamine solution is administered slowly over approximately 40 minutes. Patients remain seated or reclined in a private treatment area.
- Monitoring: Throughout the infusion, blood pressure, heart rate, and oxygen saturation are continuously monitored. Mild dissociative effects, changes in perception, or drowsiness are common and typically resolve shortly after the infusion concludes.
- Post-infusion observation: Patients remain in the clinic for a brief observation period to ensure stability before being discharged. A responsible adult must be available to provide transportation home, as driving is not permitted on the day of treatment.
Why Choosing an Experienced Provider Matters
The clinical nuances involved in IV Ketamine therapy-from precise weight-based dosing to individualized maintenance scheduling and understanding the Spravato dosing equivalence to IV Ketamine-underscore why choosing a knowledgeable, experienced provider is essential. A well-trained treatment team can make real-time adjustments to dosing and treatment frequency based on how each patient responds, maximizing the potential for positive outcomes while prioritizing safety.
Healing and Psychiatry brings dedicated expertise in both IV Ketamine and Spravato therapies to patients in Flagstaff, AZ, and the broader Northern Arizona region, including those traveling from communities such as Sedona and Prescott Valley. With a focus on individualized care and evidence-based protocols, the clinic is committed to providing a thorough, supportive treatment experience from the initial consultation through long-term maintenance.
Taking the Next Step Toward Treatment
If you or someone you know is living with treatment-resistant depression, persistent anxiety, or another condition that has not responded adequately to conventional therapies, IV Ketamine infusion therapy may be worth exploring. Understanding the details of dosing, treatment schedules, and how different ketamine-based options compare is an important first step in making informed decisions about your mental health care.
Healing and Psychiatry in Flagstaff, AZ, welcomes patients who are seeking more information about IV Ketamine therapy, treatment eligibility, and what to expect throughout the process. We encourage you to reach out to our team to schedule a consultation and discuss whether IV Ketamine may be a suitable option for your individual needs. Every treatment journey begins with a conversation, and our providers are here to guide you with care, expertise, and transparency.